Customer Center
Login | Register


Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More


Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Read More


Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.

Learn More


Luminex® Blog

Demystifying the Immune Response

Developing tools to aid in the development of vaccines and therapeutic antibodies

Our understanding of the immune system has significantly progressed since Edward Jenner published his work in 1798 describing the development of the first vaccine. Jenner recognized that dairymaids previously infected with cowpox were immune to smallpox. To test his hypothesis, Jenner infected a young boy with a cowpox pustule from the hand of a milkmaid…”

Continue Reading…

We Are Luminex

We Are Luminex


At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health.

Watch more videos >

Luminex on Twitter

RT @JoVEJournal: Scientists! Have you used #xMAP technology in your research? If yes, then check out this publication #grant @Luminex https…
h J R
Biologists have uncovered a new way in which #bacteria lay siege to neighboring cells. via @ScienceDaily
h J R
Demystifying the immune response: Developing tools to aid in the development of vaccines and therapeutic antibodies…
h J R

Latest News

March 1
Luminex Corporation To Present At The Barclays Global Healthcare Conference

February 21
Luminex Corporation Announces Initiation of Cash Dividend

February 6
Luminex Corporation Reports Fourth Quarter And Full Year 2016 Results

January 9
Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 Revenue Guidance; To Present at 35th Annual J.P. Morgan Healthcare Conference

January 4
Luminex Corporation Receives FDA Clearance for ARIES® GBS Assay

December 5
Luminex wins R&D 100 Award for ARIES Systems


NCASM Spring Meeting
March 3-4
San Francisco, CA

FAH Public Policy Conference & Business Expo
March 5-7
Washington, DC

SCACM Spring Meeting
March 23-25
Indianapolis, IN

CLMA KnowledgeLab 2017
March 27-28
Nashville, TN

March 30
Indianapolis, IN